Miguel Ruiz-Veguilla1, Luis F Callado, Maite Ferrin. 1. Grupo Psicosis y Neurodesarrollo, Instituto de Biomedicina de Sevilla, Hospital Universitario Virgen del Rocio /CSIC/Universidad de Sevilla, Spain. miguel.ruiz.veguilla.sspa@juntadeandalucia.es
Abstract
BACKGROUND: Although neurological soft signs (NSSs) have been consistently associated with schizophrenia and a variety of risk factors, few studies have focused on the association between NSSs and environmental factors such as cannabis use, particularly in patients with first episode psychosis (FEP). AIMS: To review studies that have specifically investigated the association between NSSs and cannabis use in subjects who suffer from psychosis, and more specifically in FEP. METHODS: A review of studies investigating the associations between neurological function in psychotic patients and cannabis use. RESULTS: A total of 5 studies met our inclusion criteria. Two of these included data only from patients with FEP. Four studies concluded that patients with psychosis and particularly FEP who consumed cannabis showed fewer NSSs. CONCLUSIONS: Four possible explanations are suggested for the paradoxical relationship between cannabis use and NSSs in FEP. First, heavy cannabis users present with different acute responses to cannabis use than do occasional cannabis users. Second, the psychoses developed by patients who consume cannabis follow different physio-pathological pathways that include fewer neurodevelopmental abnormalities. Third, the direct effect of cannabis on the Central Nervous System (CNS) may be responsible for the paradox. Finally,severe NSSsare associated with other clinical characteristics that would limit a subject's personal access to cannabis.
BACKGROUND: Although neurological soft signs (NSSs) have been consistently associated with schizophrenia and a variety of risk factors, few studies have focused on the association between NSSs and environmental factors such as cannabis use, particularly in patients with first episode psychosis (FEP). AIMS: To review studies that have specifically investigated the association between NSSs and cannabis use in subjects who suffer from psychosis, and more specifically in FEP. METHODS: A review of studies investigating the associations between neurological function in psychoticpatients and cannabis use. RESULTS: A total of 5 studies met our inclusion criteria. Two of these included data only from patients with FEP. Four studies concluded that patients with psychosis and particularly FEP who consumed cannabis showed fewer NSSs. CONCLUSIONS: Four possible explanations are suggested for the paradoxical relationship between cannabis use and NSSs in FEP. First, heavy cannabis users present with different acute responses to cannabis use than do occasional cannabis users. Second, the psychoses developed by patients who consume cannabis follow different physio-pathological pathways that include fewer neurodevelopmental abnormalities. Third, the direct effect of cannabis on the Central Nervous System (CNS) may be responsible for the paradox. Finally,severe NSSsare associated with other clinical characteristics that would limit a subject's personal access to cannabis.
Authors: H Bugra; E Studerus; C Rapp; C Tamagni; J Aston; S Borgwardt; A Riecher-Rössler Journal: Psychopharmacology (Berl) Date: 2013-06-12 Impact factor: 4.530
Authors: Ahmed Mhalla; Bochra Ben Mohamed; Christoph U Correll; Badii Amamou; Anouar Mechri; Lotfi Gaha Journal: Ann Gen Psychiatry Date: 2017-07-12 Impact factor: 3.455
Authors: Diego Quattrone; Laura Ferraro; Giada Tripoli; Caterina La Cascia; Harriet Quigley; Andrea Quattrone; Hannah E Jongsma; Simona Del Peschio; Giusy Gatto; Charlotte Gayer-Anderson; Peter B Jones; James B Kirkbride; Daniele La Barbera; Ilaria Tarricone; Domenico Berardi; Sarah Tosato; Antonio Lasalvia; Andrei Szöke; Celso Arango; Miquel Bernardo; Julio Bobes; Cristina Marta Del Ben; Paulo Rossi Menezes; Pierre-Michel Llorca; Jose Luis Santos; Julio Sanjuán; Andrea Tortelli; Eva Velthorst; Lieuwe de Haan; Bart P F Rutten; Michael T Lynskey; Tom P Freeman; Pak C Sham; Alastair G Cardno; Evangelos Vassos; Jim van Os; Craig Morgan; Ulrich Reininghaus; Cathryn M Lewis; Robin M Murray; Marta Di Forti Journal: Psychol Med Date: 2020-03-18 Impact factor: 7.723
Authors: Eldon Spackman; Rebecca Haines-Saah; Vishva M Danthurebandara; Laura E Dowsett; Tom Noseworthy; Fiona M Clement Journal: Healthc Policy Date: 2017-08